Unique ID issued by UMIN | UMIN000038147 |
---|---|
Receipt number | R000043481 |
Scientific Title | A prospective study about the detection myocardial damage after intensity-modulated radiotherapy using cardiac magnatic resonance imaging |
Date of disclosure of the study information | 2019/09/30 |
Last modified on | 2019/09/30 09:31:46 |
A prospective study about the detection myocardial damage after intensity-modulated radiotherapy using cardiac magnatic resonance imaging
A prospective study of myocardial changes after intensity-modulated radiation therapy
A prospective study about the detection myocardial damage after intensity-modulated radiotherapy using cardiac magnatic resonance imaging
A prospective study of myocardial changes after intensity-modulated radiation therapy
Japan |
Esophageal cancer
Radiology |
Malignancy
NO
The aim of this prospective study is to observe myocardial damage after intensity-modulated radiation therapy for esophageal cancer using cardiac magnatic resonance imaging.
Efficacy
Percentage of myocardial changes on cardiac MRI six months after intensity-modulated radiation therapy
Cumulative incidence of cardiac accident after intensity modulated radiation therapy
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Device,equipment |
Cardiac MRI is performed before and 6 mpnths after intensity-modulated radiation therapy.
20 | years-old | <= |
75 | years-old | >= |
Male and Female
(1) Esophageal cancer diagnosed histologically by biopsy.
(2) Cases scheduled for definitive radiation therapy with T1N0M0 (UICC-TNM 8th edition).
(3) Cases in which a part of the heart is assumed to be included in the radiation field.
(4) Eastern Cooperative Oncology Group performance status, 0-1.
(5) Normal kidney function (estimated glomerular filtration rate [eGFR] > 30 ml/min/1.73m2).
(6) There is written consent of the patient.
(1) Cases with heart disease and hypertension taking ACE inhibitor / ARB.
(2) Cases with serious complications other than heart disease (uncontrolled lung / liver / kidney disease, diabetes, collagen disease, intestinal obstruction, active ulcer of the digestive tract, etc.).
(3) Cases with active malignancy other than esophageal cancer.
(4) Cases with a history of chemotherapy.
(5) Cases with history of mediastinal irradiation.
(6) Cases scheduled for radiation therapy alone
(7) Female during pregnancy, within 28 days of postparturition, or during lactation
(8) Cases with pacemakers or internal metal implants
(9) Claustrophobia
(10) Severe psychological disorder.
20
1st name | Rei |
Middle name | |
Last name | Umezawa |
Tohoku University Hospital
Department of Radiation Oncology
980-8574
1-1 Seiryo-machi, Aoba-ku, Sendai
022-717-7312
reirei513@hotmail.com
1st name | Rei |
Middle name | |
Last name | Umezawa |
Tohoku University Hospital
Department of Radiation Oncology
980-8574
1-1 Seiryo-machi, Aoba-ku, Sendai
022-717-7312
reirei513@hotmail.com
Department of Radiation Oncology, Tohoku University, Graduate School of Medicine
Japan Society for the Promotion of Science
Japanese Governmental office
Ethics Committee Tohoku University Hospital
1-1 Seiryo-machi, Aoba-ku, Sendai
022-728-4105
ec@rinri.hosp.tohoku.ac.jp
NO
2019 | Year | 09 | Month | 30 | Day |
Unpublished
Preinitiation
2019 | Year | 04 | Month | 12 | Day |
2019 | Year | 10 | Month | 01 | Day |
2024 | Year | 03 | Month | 31 | Day |
2019 | Year | 09 | Month | 29 | Day |
2019 | Year | 09 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043481